Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care System

September 24, 2013 updated by: Kaiser Permanente

Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care Delivery System

This study will assess whether adding a secure message reminder to routine care improves the percentage of patients who complete a follow-up appointment with a new, documented blood pressure reading.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Hypertension is one of the leading risk factors for cardiovascular disease. Optimizing blood pressure management can help prevent adverse cardiovascular outcomes. The National Committee for Quality Assurance (NCQA) defines blood pressure control as less than 140/90 mmHg. Per this definition, less than half of Americans with hypertension are considered controlled. Literature has been published describing several ways of improving blood pressure management, but results have been variable.

Study Type

Interventional

Enrollment (Actual)

182

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Georgia
      • Atlanta, Georgia, United States, 30305
        • Kaiser Permanente Georgia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Member of Kaiser Permanente Georgia Pharmacy Cardiac Risk Service (PCRS)
  • 18-75 years of age
  • Enrolled in http://kp.org
  • Most recent documented blood pressure is greater than or equal to 140/90 mmHg

Exclusion Criteria:

  • Most recent documented blood pressure is greater than or equal to 180/110 mmHg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Routine Care
Routine care, no intervention
Active Comparator: Secure message reminder
Will receive a secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure
Other: Secure message reminder
Single secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appointment with new blood pressure reading
Time Frame: 6 weeks
Percentage of patients who complete an appointment with a new documented blood pressure reading within six weeks after distributing the secure message reminder
6 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
New appointment with new blood pressure reading
Time Frame: 6 weeks
6 weeks
Existing appointment kept with new blood pressure reading
Time Frame: 6 weeks
6 weeks
Change in antihypertensive regimen
Time Frame: 6 weeks
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kaiser Permanente

Investigators

  • Principal Investigator: Alina Kuo, PharmD, Kaiser Permanente Georgia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

September 24, 2013

First Submitted That Met QC Criteria

September 24, 2013

First Posted (Estimate)

September 27, 2013

Study Record Updates

Last Update Posted (Estimate)

September 27, 2013

Last Update Submitted That Met QC Criteria

September 24, 2013

Last Verified

September 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GA-11AKuo-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe